Tag: Myasthenia Gravis Treatment Market Growth Share
Myasthenia Gravis Treatment Market Demand by Top Market Players Valeant Pharmaceuticals International, Novartis Pharmaceuticals Corporation, Apotex Corporation, Teva Pharmaceutical Industries Ltd.
The global myasthenia gravis treatment market was valued at around USD 1,011.1 million in 2017 and is expected to grow at a CAGR of 12.1% during the forecast period
0
0
0
1 Feb, 05:30 AM
